106 related articles for article (PubMed ID: 8386088)
21. 5-HT2-receptor antagonists: alpha 1- vs. 5-HT2-receptor blocking properties in blood vessels.
Cohen ML; Schenck KW; Kurz KD
J Cardiovasc Pharmacol; 1988; 11 Suppl 1():S25-9. PubMed ID: 2459510
[TBL] [Abstract][Full Text] [Related]
22. Regulation of serotonin 5-HT2C receptors in the rat choroid plexus after acute clozapine treatment.
Kuoppamäki M; Seppälä T; Syvälahti E; Hietala J
Eur J Pharmacol; 1994 Oct; 269(2):201-8. PubMed ID: 7851496
[TBL] [Abstract][Full Text] [Related]
23. High and low affinity 5-HT2 and 5-HT1C binding sites: responses to neonatal 5,7-DHT lesions in rat brain.
Pranzatelli MR; Gregory CM
Cytobios; 1993; 75(302-303):197-209. PubMed ID: 8243108
[TBL] [Abstract][Full Text] [Related]
24. Quantitative autoradiographic mapping of serotonin receptors in the rat brain. II. Serotonin-2 receptors.
Pazos A; Cortés R; Palacios JM
Brain Res; 1985 Nov; 346(2):231-49. PubMed ID: 4052777
[TBL] [Abstract][Full Text] [Related]
25. Selective visualization of rat brain 5-HT2A receptors by autoradiography with [3H]MDL 100,907.
López-Giménez JF; Mengod G; Palacios JM; Vilaró MT
Naunyn Schmiedebergs Arch Pharmacol; 1997 Oct; 356(4):446-54. PubMed ID: 9349630
[TBL] [Abstract][Full Text] [Related]
26. [125I]LSD labels 5-HT1C recognition sites in pig choroid plexus membranes. Comparison with [3H]mesulergine and [3H]5-HT binding.
Hoyer D; Srivatsa S; Pazos A; Engel G; Palacios JM
Neurosci Lett; 1986 Sep; 69(3):269-74. PubMed ID: 3763057
[TBL] [Abstract][Full Text] [Related]
27. Identification of binding sites for SR 46349B, a 5-hydroxytryptamine2 receptor antagonist, in rodent brain.
Rinaldi-Carmona M; Congy C; Pointeau P; Vidal H; Brelière JC; Le Fur G
Life Sci; 1994; 54(2):119-27. PubMed ID: 8277817
[TBL] [Abstract][Full Text] [Related]
28. Modulation of 5-HT1C receptors and phosphoinositide system by ethanol consumption in rat brain and choroid plexus.
Pandey SC; Dubey MP; Piano MR; Schwertz DW; Davis JM; Pandey GN
Eur J Pharmacol; 1993 Sep; 247(1):81-8. PubMed ID: 8258364
[TBL] [Abstract][Full Text] [Related]
29. Naphthosultam derivatives: a new class of potent and selective 5-HT2 antagonists.
Malleron JL; Comte MT; Gueremy C; Peyronel JF; Truchon A; Blanchard JC; Doble A; Piot O; Zundel JL; Huon C
J Med Chem; 1991 Aug; 34(8):2477-83. PubMed ID: 1908521
[TBL] [Abstract][Full Text] [Related]
30. The effect of long-term treatment with amine-depleting drugs or chlorpromazine on alpha-adrenoreceptors and 5-HT2 receptors in the brain of the rat.
Hong M; Roots EJ; Jenner P; Marsden CD
Neuropharmacology; 1988 May; 27(5):519-27. PubMed ID: 2899303
[TBL] [Abstract][Full Text] [Related]
31. The interaction of RS 25259-197, a potent and selective antagonist, with 5-HT3 receptors, in vitro.
Wong EH; Clark R; Leung E; Loury D; Bonhaus DW; Jakeman L; Parnes H; Whiting RL; Eglen RM
Br J Pharmacol; 1995 Feb; 114(4):851-9. PubMed ID: 7773546
[TBL] [Abstract][Full Text] [Related]
32. Regulation of 5-HT2 receptors in rat cortex. Studies with a putative selective agonist and an antagonist.
Pranzatelli MR
Biochem Pharmacol; 1991 Aug; 42(5):1099-105. PubMed ID: 1872895
[TBL] [Abstract][Full Text] [Related]
33. The binding of serotonergic ligands to the porcine choroid plexus: characterization of a new type of serotonin recognition site.
Pazos A; Hoyer D; Palacios JM
Eur J Pharmacol; 1984 Nov; 106(3):539-46. PubMed ID: 6519175
[TBL] [Abstract][Full Text] [Related]
34. Putative selective 5-HT-2 antagonists block serotonin 5-HT-1c receptors in the choroid plexus.
Sanders-Bush E; Breeding M
J Pharmacol Exp Ther; 1988 Oct; 247(1):169-73. PubMed ID: 3139864
[TBL] [Abstract][Full Text] [Related]
35. Characterization of NK1 and NK2 tachykinin receptors in guinea-pig and rat bronchopulmonary and vascular systems.
Floch A; Fardin V; Cavero I
Br J Pharmacol; 1994 Mar; 111(3):759-68. PubMed ID: 7517328
[TBL] [Abstract][Full Text] [Related]
36. Occupancy of central neurotransmitter receptors by risperidone, clozapine and haloperidol, measured ex vivo by quantitative autoradiography.
Schotte A; Janssen PF; Megens AA; Leysen JE
Brain Res; 1993 Dec; 631(2):191-202. PubMed ID: 7510574
[TBL] [Abstract][Full Text] [Related]
37. Characterization of flufylline, fluprofylline, ritanserin, butanserin and R 56413 with respect to in-vivo alpha 1-,alpha 2- and 5-HT2-receptor antagonism and in-vitro affinity for alpha 1-,alpha 2- and 5-HT2-receptors: comparison with ketanserin.
Korstanje C; Sprenkels R; Doods HN; Hugtenburg JG; Boddeke E; Batink HD; Thoolen MJ; Van Zwieten PA
J Pharm Pharmacol; 1986 May; 38(5):374-9. PubMed ID: 2872314
[TBL] [Abstract][Full Text] [Related]
38. Ketanserin analogues: structure-affinity relationships for 5-HT2 and 5-HT1C serotonin receptor binding.
Herndon JL; Ismaiel A; Ingher SP; Teitler M; Glennon RA
J Med Chem; 1992 Dec; 35(26):4903-10. PubMed ID: 1479590
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of the receptor selectivity of the H3 receptor antagonists, iodophenpropit and thioperamide: an interaction with the 5-HT3 receptor revealed.
Leurs R; Tulp MT; Menge WM; Adolfs MJ; Zuiderveld OP; Timmerman H
Br J Pharmacol; 1995 Oct; 116(4):2315-21. PubMed ID: 8564266
[TBL] [Abstract][Full Text] [Related]
40. Repeated administration of MDMA causes transient down-regulation of serotonin 5-HT2 receptors.
Scheffel U; Lever JR; Stathis M; Ricaurte GA
Neuropharmacology; 1992 Sep; 31(9):881-93. PubMed ID: 1359444
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
